STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Clinical trials for STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could decide who gets extra immunotherapy after bladder cancer surgery
Disease control Recruiting nowThis study looks at whether a simple blood test can find leftover cancer DNA after surgery for bladder or urinary tract cancer. Patients with detectable DNA may need extra treatment with immunotherapy drugs (nivolumab with or without relatlimab) to lower the risk of cancer coming…
Matched conditions: STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
Scientists hunt for clues to cancer resistance in tissue samples
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 1,500 people with prostate or bladder cancer that has returned or spread. Researchers will analyze these samples to find new biomarkers and understand why some cancers stop responding to treatment. The goal is to improve future th…
Matched conditions: STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC